Need For A Smarter Regulatory System To Ensure Access To Affordable Biologics: The Biosimilars

New Drug Approvals

by

Kiran Mazumdar Shaw, MD, BIOCON

The global pharmaceutical industry is going through a paradigm change as biologics such as monoclonal antibodies and recombinant proteins find greater acceptance for treating a wide range of chronic diseases.

Today biologics make for up half of the top 10 best-selling drugs worldwide.

http://kiranmazumdarshaw.blogspot.in/2013/08/need-for-smarter-regulatory-system-to_13.html

View original post